MACULAR DEGENERATION
Clinical trials for MACULAR DEGENERATION explained in plain language.
Never miss a new study
Get alerted when new MACULAR DEGENERATION trials appear
Sign up with your email to follow new studies for MACULAR DEGENERATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New eye drug faricimab aims to control wet AMD with fewer shots
Disease control Not yet recruitingThis phase 4 trial will test the drug faricimab (Vabysmo) in 64 people with wet age-related macular degeneration (AMD). Participants will receive eye injections every 4 weeks for 4 doses, then a treat-and-extend schedule based on disease activity. The study also measures biomarke…
Matched conditions: MACULAR DEGENERATION
Phase: PHASE4 • Sponsor: Junyeop Lee • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
AI eye doctor: new study aims to spot Blindness-Causing diseases
Diagnosis Not yet recruitingThis study will develop and test an artificial intelligence system to detect common eye diseases like glaucoma, cataracts, and diabetic retinopathy using 15,000 existing eye images from Costa Rican patients. The goal is to create a tool that works accurately for local populations…
Matched conditions: MACULAR DEGENERATION
Sponsor: Marisse Masis-Solano • Aim: Diagnosis
Last updated Jun 27, 2026 12:01 UTC
-
New study hopes to help people with blurry center vision read again
Knowledge-focused Not yet recruitingThis study looks at whether shifting text to a different part of the eye can help people with central vision loss read faster and more accurately. Researchers will test 100 participants with conditions like macular degeneration using various reading tasks. The goal is to find bet…
Matched conditions: MACULAR DEGENERATION
Phase: NA • Sponsor: University of Minnesota • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:54 UTC